Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia
NCT00517712Phase 3Unknown
- Sponsor
- Christian Medical College, Vellore
- Start
- Jun 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of arsenic trioxide in acute promyelocytic leukemia (APL), sponsored by Christian Medical College, Vellore. Status: unknown.
02
Drugs
arsenic trioxide
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00517712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517712.